17 min listen
Special Populations and Immune Checkpoint Inhibitors: Are They Safe?
Special Populations and Immune Checkpoint Inhibitors: Are They Safe?
ratings:
Length:
31 minutes
Released:
Feb 26, 2021
Format:
Podcast episode
Description
In this activity, three experts discuss how to incorporate immune checkpoint inhibitor therapy into the management of individuals classified as part of the “special population” of patients not generally included in clinical trials. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/946383?src=mkm_podcast_addon_946383
Released:
Feb 26, 2021
Format:
Podcast episode
Titles in the series (100)
Aspirin in 2019: What Every Physician Needs to Know: Dr Angiolillo reviews the latest evidence and guidelines on the use of aspirin in primary prevention. --- Full URLs: Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/914445?src=mkm_podcast_addon_914445 by Keeping Current CME